New Jersey Business NJ

GD3 acquires Comparative Biosciences, expands services to GLP-based studies

Return On Information New Jersey

Aug 5, 2020

Genesis Drug Discovery & Development, a Hamilton-based member of Genesis Biotechnology Group, announced on Wednesday it has acquired Comparative Biosciences Inc., a Contact Researc…

Read the full story at Return On Information New Jersey

GD3 acquires Comparative Biosciences, expands services to GLP-based studies

More from New Jersey Business

Statement: Sherrill administration should have delayed New Jersey's new independent contractor regulations

New Report Says N.J. Needs More Affordable Homes for Sale, Not Just Buyer Assistance

100,000 Square Foot Expansion Breaks Ground at Liberty Science Center

Panoramic Manhattan Views and a Private Terrace Define This Avora Residence

New Jersey cannot afford to send mixed signals to business

Team Moza Debuts Casa One, Featuring 196 Rental Residences in Journal Square

Princeton Community Housing to Build Affordable Apartments on Former DPW Site

All-Affordable 113-Unit Development Moves Forward in Wayne